发布求助
文献互助 智能选刊 最新文献

Journal of Managed Care Pharmacy最新文献

筛选
英文 中文
Electronic Prescribing in Ambulatory Care: A Market Primer and Implications for Managed Care Pharmacy 电子处方在门诊护理:市场入门和管理护理药房的影响
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.2001.7.2.115
Bob Elson
{"title":"Electronic Prescribing in Ambulatory Care: A Market Primer and Implications for Managed Care Pharmacy","authors":"Bob Elson","doi":"10.18553/JMCP.2001.7.2.115","DOIUrl":"https://doi.org/10.18553/JMCP.2001.7.2.115","url":null,"abstract":"","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67489154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Health Care Plan Perspective 医疗保健计划的观点
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.2001.7.S2.10
W. Berger, D. Giaquinta, E. Cannon, G. Ledgerwood, O. Shoheiber
{"title":"The Health Care Plan Perspective","authors":"W. Berger, D. Giaquinta, E. Cannon, G. Ledgerwood, O. Shoheiber","doi":"10.18553/JMCP.2001.7.S2.10","DOIUrl":"https://doi.org/10.18553/JMCP.2001.7.S2.10","url":null,"abstract":"","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67490158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Cost of Managing Diabetes Mellitus: Focus on the Oral Pharmacologic Management of Type II Diabetes 糖尿病管理的成本:II型糖尿病的口服药物管理
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.1999.5.2.113
John R. White
{"title":"The Cost of Managing Diabetes Mellitus: Focus on the Oral Pharmacologic Management of Type II Diabetes","authors":"John R. White","doi":"10.18553/JMCP.1999.5.2.113","DOIUrl":"https://doi.org/10.18553/JMCP.1999.5.2.113","url":null,"abstract":"OBJECTIVE: To evaluate the pharmacologic management of Type II diabetes in terms of the effect of various regimens on the metabolic abnormalities present in patients, while considering the importance of medication cost when designing a therapeutic regimen. DESIGN: Literature review. RESULTS: The primary lesion in Type II disease which causes hyperglycemia is probably insulin resistance. Hyperglycemia often is accompanied by other metabolic abnormalities, such as hyperinsulinemia, hyperlipidemia, hypertension, and weight gain. Recently, new oral medications have been introduced, including metformin and troglitazone, which address multiple metabolic abnormalities of Type II disease. Data has proven a conclusive link between poor glycemic control and the appearance and progression of complications. CONCLUSION: While cost of medication should be considered, the most effective method of cost savings in the management of Type II disease is via strict glycemic control with medications which do not adversely affe...","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67487706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Criteria for the Use of Tramadol in Adult Patients: Medication-Use Evaluation Guidelines 曲马多在成人患者中的使用标准:用药评价指南
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.1999.5.6.492
J. Generali
{"title":"Criteria for the Use of Tramadol in Adult Patients: Medication-Use Evaluation Guidelines","authors":"J. Generali","doi":"10.18553/JMCP.1999.5.6.492","DOIUrl":"https://doi.org/10.18553/JMCP.1999.5.6.492","url":null,"abstract":"OBJECTIVE: To develop a practical medication-use evaluation (MUE) tool flexible enough to be used in a variety of practice settings. SETTING: Institutional health care systems or managed care organizations, although the format may be adapted for use by consultant pharmacists. DESIGN: This MUE has been designed for use as part of a comprehensive outcome monitoring program. It focuses on a particular agent (tramadol hydrochloride) that has significant cost and usage implications. MAIN OUTCOME MEASURES: Appropriate patient populations and desired therapeutic outcomes can be identified with the use of this MUE. Customized interventions that are appropriate to each organization may. RESULTS: This MUE can provide a framework for institutional health care systems and' MCOs to use in developing a comprehensive monitoring program for tramadol hydrochloride and an oral analgesic. CONCLUSION: Effective high-quality pharmaceutical care incorporates the use of assessment methods that monitor patient outcomes and medic...","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67488300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Concern about Foreign-Source Pharmacy Internet Providers 对外资医药互联网服务提供商的关注
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.2001.7.5.335
M. Shepherd
{"title":"Concern about Foreign-Source Pharmacy Internet Providers","authors":"M. Shepherd","doi":"10.18553/JMCP.2001.7.5.335","DOIUrl":"https://doi.org/10.18553/JMCP.2001.7.5.335","url":null,"abstract":"","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67489732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An In-Home Synagis Program for RSV Prevention in High-Risk Infants 在高危婴儿中预防呼吸道合胞病毒的家庭合成计划
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.2001.7.6.476
Mary P. Weber, S. Reno, R. Hornbake, A. Shillington
{"title":"An In-Home Synagis Program for RSV Prevention in High-Risk Infants","authors":"Mary P. Weber, S. Reno, R. Hornbake, A. Shillington","doi":"10.18553/JMCP.2001.7.6.476","DOIUrl":"https://doi.org/10.18553/JMCP.2001.7.6.476","url":null,"abstract":"OBJECTIVES: To evaluate and describe outcomes associated with a novel in- home administration program of respi- ratory syncytial virus (RSV) prophylaxis with palivizumab; to analyze health resource utilization and cost outcomes; and to assess parental satisfaction with in-home administration of prophy- laxis for high-risk children. DESIGN: Descriptive program evalua- tion. RESULTS: Compared with published reports of office, outpatient, or clinic- based RSV prophylaxis with palivizumab, in-home prophylaxis demonstrated low incidence of total hospitalizations (11.4% versus 14.4%) and RSV-related hospitalizations (2.3% versus 4.8%). Less than 10% of patients required an ED visit and only 1% of those were related to RSV ill- ness. Only one of the hospitalized infants required ICU admission. One- fourth of the patients experienced fever or ear infection; 43.2% devel- oped cold symptoms. In-home palivizumab prophylaxis has the potential for saving $214 per patient over drug administration and hospital- ization costs. Parental satisfaction with the in-home program was 98.6%, leading to high compliance; less than 2% of patients discontinued the program due to noncompliance. CONCLUSIONS: In-home administra- tion of palivizumab RSV prophylaxis can provide favorable outcomes, high parent satisfaction, and potential cost savings. Incidence of RSV-related hospitalizations among patients given prophylaxis at home was substantially lower than has been reported with outpatient or clinic-based prophylaxis. Compliance was excellent due to ease of administration of intramuscular palivizumab, convenience for families with multiple or premature infants or infants requiring cumbersome med- ical devices, and parents' desire to minimize the risk of exposure to RSV and other communicable diseases in clinics. Improved clinical outcomes observed with in-home prophylaxis may translate into substantial cost savings for health care purchasers.","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67490447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
AMCP Speakers Reinhardt and Satcher Paint Bright Future AMCP发言人Reinhardt和Satcher描绘了光明的未来
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.1997.3.1.11
C. Sardinha
{"title":"AMCP Speakers Reinhardt and Satcher Paint Bright Future","authors":"C. Sardinha","doi":"10.18553/JMCP.1997.3.1.11","DOIUrl":"https://doi.org/10.18553/JMCP.1997.3.1.11","url":null,"abstract":"","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68349651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Method Is Everything: Evaluating Results by Study Design 方法决定一切:通过研究设计评估结果
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.1997.3.1.66
D. Mednick
{"title":"Method Is Everything: Evaluating Results by Study Design","authors":"D. Mednick","doi":"10.18553/JMCP.1997.3.1.66","DOIUrl":"https://doi.org/10.18553/JMCP.1997.3.1.66","url":null,"abstract":"OBJECTIVE: To review advantages and disadvantages of commonly used study design strategies and examine issues in interpretation of study results including bias and confounding. DATA SOURCES: Clinical literature, established epidemiologic texts. STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: The increasing flow of research reports on various therapeutic agents and procedures places managed care pharmacists in the position of evaluating the clinical relevance of new information and its applicability to clinical decision-making in their organizations. A solid understanding of study design strategies such as cohort, case-control, and clinical trials, and the flaws inherent in each, is invaluable for accurate interpretation of any study results. Some design strategies are more appropriate than others to answer certain clinical questions. The randomized, controlled, blinded clinical trial is the most reliable design for assessing therapeutic effects of pharmacologic agents. CO...","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68350536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Formularies: Real Opportunities to Improve MCO Efficiency 药物处方:提高mcco效率的真正机会
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.1997.3.3.254
F. Curtiss
{"title":"Drug Formularies: Real Opportunities to Improve MCO Efficiency","authors":"F. Curtiss","doi":"10.18553/JMCP.1997.3.3.254","DOIUrl":"https://doi.org/10.18553/JMCP.1997.3.3.254","url":null,"abstract":"","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68350876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications of Pharmacoeconomics for Managed Care Pharmacy 药物经济学在管理式医疗药房中的应用
Journal of Managed Care Pharmacy Pub Date : 2015-09-15 DOI: 10.18553/JMCP.1997.3.6.720
C. Mullins
{"title":"Applications of Pharmacoeconomics for Managed Care Pharmacy","authors":"C. Mullins","doi":"10.18553/JMCP.1997.3.6.720","DOIUrl":"https://doi.org/10.18553/JMCP.1997.3.6.720","url":null,"abstract":"OBJECTIVE: To describe different types of pharmacoeconomic analyses that can be useful for evaluating drug products and managed care pharmacy services. This article addresses issues to be considered for a pharmacoeconomic study of pharmaceutical care and how to critically analyze the pharmacoeconomic literature. DATA SOURCES: Literature and Internet references, ongoing studies. DATA SYNTHESIS: Not Applicable. CONCLUSION: Pharmacoeconomics is changing the practice of managed care pharmacy. Pharmacists' economics literature as part of their professional services. In addition, pharmacists should document their pharmaceutical care interventions and the effects on patient outcomes.","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.18553/JMCP.1997.3.6.720","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68352187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信